obviousness type double patenting

A Wake Up Call about Obviousness-type Double Patenting – the Effect of In re Cellect

What many seem to have understood from Gilead Sciences, Inc. v. Natco Pharma Limited (Fed. Cir. 2014), has been clearly set forth in the recent...

MWZB Partner Ryan Pool to speak a AIPLA

We are proud to announce that Ryan Pool has been selected to speak at the AIPLA Mid-Winter Institute IP Practice in Japan Committee Pre-Meeting to be...


MWZB Newsletter Signup